期刊
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
卷 299, 期 18, 页码 2151-2163出版社
AMER MEDICAL ASSOC
DOI: 10.1001/jama.299.18.2151
关键词
-
资金
- NCI NIH HHS [U01 CA080098, U01 CA080098-10, CA 80098, U10 CA080098, U01 CA079778, U10 CA079778, CA 79778] Funding Source: Medline
Context Screening ultrasound may depict small, node- negative breast cancers not seen on mammography. Objective To compare the diagnostic yield, defined as the proportion of women with positive screen test results and positive reference standard, and performance of screening with ultrasound plus mammography vs mammography alone in women at elevated risk of breast cancer. Design, Setting, and Participants From April 2004 to February 2006, 2809 women, with at least heterogeneously dense breast tissue in at least 1 quadrant, were recruited from 21 sites to undergo mammographic and physician- performed ultrasonographic examinations in randomized order by a radiologist masked to the other examination results. Reference standard was defined as a combination of pathology and 12- month follow-up and was available for 2637 ( 96.8%) of the 2725 eligible participants. Main Outcome Measures Diagnostic yield, sensitivity, specificity, and diagnostic accuracy ( assessed by the area under the receiver operating characteristic curve) of combined mammography plus ultrasound vs mammography alone and the positive predictive value of biopsy recommendations for mammography plus ultrasound vs mammography alone. Results Forty participants ( 41 breasts) were diagnosed with cancer: 8 suspicious on both ultrasound and mammography, 12 on ultrasound alone, 12 on mammography alone, and 8 participants ( 9 breasts) on neither. The diagnostic yield for mammography was 7.6 per 1000 women screened ( 20 of 2637) and increased to 11.8 per 1000 ( 31 of 2637) for combined mammography plus ultrasound; the supplemental yield was 4.2 per 1000 women screened ( 95% confidence interval [ CI], 1.1- 7.2 per 1000; P=. 003 that supplemental yield is 0). The diagnostic accuracy for mammography was 0.78 ( 95% CI, 0.67- 0.87) and increased to 0.91 ( 95% CI, 0.84- 0.96) for mammography plus ultrasound ( P=. 003 that difference is 0). Of 12 supplemental cancers detected by ultrasound alone, 11 ( 92%) were invasive with a median size of 10 mm( range, 5- 40 mm; mean [ SE], 12.6 [ 3.0] mm) and 8 of the 9 lesions ( 89%) reported had negative nodes. The positive predictive value of biopsy recommendation after full diagnostic workup was 19 of 84 for mammography ( 22.6%; 95% CI, 14.2%- 33%), 21 of 235 for ultrasound ( 8.9%, 95% CI, 5.6%- 13.3%), and 31 of 276 for combined mammography plus ultrasound ( 11.2%; 95% CI. 7.8%- 15.6%). Conclusions Adding a single screening ultrasound to mammography will yield an additional 1.1 to 7.2 cancers per 1000 high- risk women, but it will also substantially increase the number of false positives. Trial Registration clinicaltrials. gov Identifier: NCT00072501.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据